Influence of VEGFA gene polymorphisms rs2010963 and rs699947 on clinical and laboratory indicators in diabetic retinopathy among patients with type 2 diabetes mellitus

A.S. Gudz, S.V. Ziablitsev, G.E. Zaharevich

Abstract


Background. A key factor of neoangiogenesis deve­lopment in diabetic retinopathy (DR) among patients with type 2 diabetes mellitus (DM) is vascular endothelial growth factor A (VEGFA). The important role of genetic polymorphisms of the VEGFA gene indicates a number of studies and meta-analyzes, that have shown their association with DR, especially with its proliferative variant, which varies in different populations. Accordingly, the purpose of this work was to find out the influence of the polymorphic genotypes rs2010963 and rs699947 of the VEGFA gene on clinical and laboratory parameters of DR in DM patients from Ukrainian population. Materials and methods. The study involved 302 patients with type 2 diabetes mellitus and DR. Diagnosis was established according to the international clinical classification adopted by the American Academy of Ophthalmology (2003). The control group consisted of 98 people who did not have DM and DR, as well as other ophthalmic diseases. All patients were operated on cataract. In the intraocular fluid collected during the surgery, the VEGFA content was determined by the immunoassay method. Analysis of the polymorphic DNA loci of the VEGFA gene: rs2010963 and rs699947 was performed in a real time polymerase chain reaction using TaqMan Mutation Detection Assays (Thermo Fisher Scientific, USA). Results. An analysis of the study results showed that rs2010963 polymorphism had an effect on the intraocular fluid VEGFA level (maximum — under the C/C risk genotype). This polymorphism was related to the sex (the genotype C/C was more common in men than in women: 3 : 1), the presence of proliferative DR (most often was determined by the presence of the genotype C/C: 45.4 %) and neovascularization of the optic disc (most often determined by the pre­sence of heterozygotes G/C: 21.4 %). Polymorphism rs699947 had an effect on the visual acuity (the minimum was available in the genotype C/C), the thickness of the retina (the maximum value — in the genotype C/C), the content of VEGFA in intraocular fluid (maximum level — in the genotype C/C), as well as the presence of proliferative DR and hemophthalm (most often determined by the presence of the genotype C/C, respectively: 44.7 and 27.7 %). Conclusions. The pathogenetic effect of the risk of genotype C/C rs2010963 was more often detected in men, realized due to the high level of VEGFA in intraocular fluid and manifested by the maximum incidence of proliferative DR. The pathogenetic effect of the genotype C/C rs699947 risk has also been realized due to the high intraocular VEGFA level, resulting in decreased visual acuity and retinal thickening and manifested as the maximum rate of proliferative DR and hemophthalm.


Keywords


diabetic retinopathy; VEGFA gene polymorphism; rs2010963; rs699947

References


Komisarenko YuI. Correction by vitamin D3 of disturbed metabolism in patients with diabetes mellitus types 1 and 2. The Ukrainian Biochemical Journal. 2014;86(1):111-116. (in Ukrainian).

Tron'ko MD, Chernobrov AD. Epidemiology of diabetes mellitus in Ukraine. Zdorov’ja Ukrai'ny. 2005;18(127):15. (in Ukrainian).

Vlasenko MV. Diabetes mellitus: diagnostics and monitoring. Liky Ukrai'ny. 2013;9-10:17-18. (in Ukrainian).

Dedov II, Smirnova OM. Diabetic retinopathy; current problems. Sakharnyj diabet. 2008;3:4-7. (in Russian).

Pankiv VI. Diabetes mellitus: diagnostic criteria, etiology and pathogenesis. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2013;8:53-64. (in Ukrainian).

Balashevich LI, Brzheskii VV, Izmailov АC, authors. Balashevich LI, editor. Glaznye proiavleniia diabeta [Eye displays of diabetes mellitus]. Saint-Petersburg: SPMAPE; 2004. 382 p. (in Russian).

Wu CM, Wu AM, Young BK, Wu DJ, Margo CF, Greenberg PB. An appraisal of clinical practice guidelines for diabetic retinopathy. Am J Med Qual. 2016 Jul;31(4):370-5. doi: 10.1177/1062860615574863.

Agarwal A, Soliman MK, Sepah YJ, Do DV, Nguyen QD. Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics. Pharmgenomics Pers Med. 2014;7:399-409. doi: 10.2147/PGPM.S52821.

Schulkin AV, Kolesnikov AV, Barenina OI, Nikiforov AA. Genetic markers of diabetic retinopathy. Fundamental research. 2014;4(2):411-414 (in Russian).

Grassi MA, Tikhomirov A, Ramalingam S, Below JE, Cox NJ, Nicolae DL. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet. 2011 Jun 15;20(12):2472-81. doi: 10.1093/hmg/ddr121.

Han L, Zhang L, Xing W, et al. The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta-analysis of 11 case-control studies. J Diabetes Res. 2014;2014:805801. doi: 10.1155/2014/805801.

Chun MY, Hwang HS, Cho HY, et al. Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. J Clin Endocrinol Metab. 2010 Jul;95(7):3547-51. doi: 10.1210/jc.2009-2719.

Qiu M, Xiong W, Liao H, Li F. VEGF-634G>C polymorphism and diabetic retinopathy risk: a meta-analysis. Gene. 2013 Apr 15;518(2):310-5. doi: 10.1016/j.gene.2013.01.018.

Xie XJ, Yang YM, Jiang JK, Lu YQ. Association between the vascular endothelial growth factor single nucleotide polymorphisms and diabetic retinopathy risk: a meta-analysis. J Diabetes. 2017 Aug;9(8):738-753. doi: 10.1111/1753-0407.12480.

Priščáková P, Minárik G, Repiská V. Candidate gene studies of diabetic retinopathy in human. Mol Biol Rep. 2016 Dec;43(12):1327-1345. doi: 10.1007/s11033-016-4075-y.

Lu Y, Ge Y, Shi Y, Yin J, Huang Z. Two polymorphisms (rs699947, rs2010963) in the VEGFA gene and diabetic retinopathy: an updated meta-analysis. BMC Ophthalmol. 2013 Oct 16;13:56. doi: 10.1186/1471-2415-13-56.

Vailati FB, Crispim D, Sortica DA, Souza BM, Brondani LA, Canani LH. The C allele of -634G/C polymorphism in the VEGFA gene is associated with increased VEGFA gene expression in human retinal tissue. Invest Ophthalmol Vis Sci. 2012 Sep 21;53(10):6411-5. doi: 10.1167/iovs.12-9727.

Chen CF, Liou SW, Wu HH, et al. Regulatory SNPs alter the gene expression of diabetic retinopathy associated secretary factors. Int J Med Sci. 2016 Sep 12;13(9):717-23. doi: 10.7150/ijms.16345.

Fan X, Wu Q, Li Y, et al. Association of polymorphisms in the vascular endothelial growth factor gene and its serum levels with diabetic retinopathy in Chinese patients with type 2 diabetes: a cross-sectional study. Chin Med J (Engl). 2014;127(4):651-7. PMID: 24534217.




DOI: https://doi.org/10.22141/2224-0721.13.7.2017.115745

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru